In tau-expressing models, kinases and phosphatases comprised the major classes of modifiers of the tauopathy [14], and cytoskeleton proteins and molecular chaperones have been identified as modulators of mutant tau-induced neurodegeneration [15]. The gene discussed is MAPT; the disease is tauopathy.